Psychedelics and Legislation

Shane discusses his experiences with psychedelics and the upcoming legal changes, questioning the rationale behind the DEA's classification of these substances. He highlights the paradox of organizations like the DEA maintaining their power at the expense of scientific progress, while also shedding light on the role of the FDA in psychedelic research. The conversation reveals a deeper issue of how historical decisions, driven by political motives, continue to shape current drug policies.